WAKE-UP试验中FLAIR定量信号强度与溶栓疗效的关系
该研究为WAKE-UP随机对照试验的事后分析,定量测量433例未知发病时间卒中患者的FLAIR相对信号强度(FLAIR-rSI),分析其与静脉阿替普酶疗效的交互作用。结果显示FLAIR-rSI越高,溶栓对90天功能结局(mRS 0-2)的疗效越差,提示定量FLAIR信号强度可反映发病时间并影响治疗效应。
要点
- 在视觉判定DWI-FLAIR不匹配的患者中,定量FLAIR-rSI越高,溶栓疗效越差。
- FLAIR-rSI与治疗交互作用对mRS 0-2显著(P=0.004),对mRS 0-1和移位分析未达显著。
- 定量FLAIR信号强度可能辅助评估未知发病时间卒中患者的溶栓获益。
核心结论
- 在WAKE-UP试验中视觉判定无显著FLAIR高信号的患者,DWI病灶FLAIR-rSI越高与静脉溶栓疗效降低相关。
研究设计与样本
- WAKE-UP随机对照试验的事后分析,共纳入503例患者,其中433例(86%)成功定量FLAIR-rSI。
- FLAIR-rSI测量为病灶信号强度相对于对侧半球镜像区域信号强度的比值。
- 采用二元逻辑回归分析FLAIR-rSI与治疗对90天mRS的交互作用,调整基线NIHSS和病灶体积。
主要发现
- 平均FLAIR-rSI为1.06(SD 0.09)。
- FLAIR-rSI与治疗交互作用对mRS 0-1不显著(P=0.169),对移位分析不显著(P=0.086),对mRS 0-2显著(P=0.004)。
- 随着FLAIR-rSI增加,临床终点上的治疗效应呈现平滑持续下降趋势。
关键数值与推荐
- 有利结局定义为mRS 0-1,独立结局定义为mRS 0-2,另采用mRS移位分析。
- 交互作用检验P值:mRS 0-1为P=0.169,移位分析P=0.086,mRS 0-2为P=0.004。
临床怎么用
- 对于视觉判定DWI-FLAIR不匹配的未知发病时间卒中患者,可考虑定量FLAIR-rSI以辅助评估溶栓获益可能性。
- FLAIR-rSI较高提示溶栓疗效可能降低,应与已知的发病时间延长效应平行解读。
局限性
- 本研究为WAKE-UP试验的事后分析,结果需前瞻性验证。
- 仅86%的WAKE-UP患者成功定量FLAIR-rSI,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background and Purpose- Relative signal intensity of acute ischemic stroke lesions in fluid-attenuated inversion recovery (fluid-attenuated inversion recovery relative signal intensity [FLAIR-rSI]) magnetic resonance imaging is associated with time elapsed since stroke onset with higher intensities signifying longer time intervals. In the randomized controlled WAKE-UP trial (Efficacy and Safety of MRI-Based Thrombolysis in Wake-Up Stroke Trial), intravenous alteplase was effective in patients with unknown onset stroke selected by visual assessment of diffusion weighted imaging fluid-attenuated inversion recovery mismatch, that is, in those with no marked fluid-attenuated inversion recovery hyperintensity in the region of the acute diffusion weighted imaging lesion. In this post hoc analysis, we investigated whether quantitatively measured FLAIR-rSI modifies treatment effect of intravenous alteplase. Methods- FLAIR-rSI of stroke lesions was measured relative to signal intensity in a mirrored region in the contralesional hemisphere. The relationship between FLAIR-rSI and treatment effect on functional outcome assessed by the modified Rankin Scale (mRS) after 90 days was analyzed by binary logistic regression using different end points, that is, favorable outcome defined as mRS score of 0 to 1, independent outcome defined as mRS score of 0 to 2, ordinal analysis of mRS scores (shift analysis). All models were adjusted for National Institutes of Health Stroke Scale at symptom onset and stroke lesion volume. Results- FLAIR-rSI was successfully quantified in stroke lesions in 433 patients (86% of 503 patients included in WAKE-UP). Mean FLAIR-rSI was 1.06 (SD, 0.09). Interaction of FLAIR-rSI and treatment effect was not significant for mRS score of 0 to 1 (P=0.169) and shift analysis (P=0.086) but reached significance for mRS score of 0 to 2 (P=0.004). We observed a smooth continuing trend of decreasing treatment effects in relation to clinical end points with increasing FLAIR-rSI. Conclusions- In patients in whom no marked parenchymal fluid-attenuated inversion recovery hyperintensity was detected by visual judgement in the WAKE-UP trial, higher FLAIR-rSI of diffusion weighted imaging lesions was associated with decreased treatment effects of intravenous thrombolysis. This parallels the known association of treatment effect and elapsing time of stroke onset.
引用
- Cheng B, Boutitie F, Nickel A, et al. Quantitative Signal Intensity in Fluid-Attenuated Inversion Recovery and Treatment Effect in the WAKE-UP Trial. Stroke. 2019. PMID: 31662118. doi:10.1161/STROKEAHA.119.027390
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。